In a recent large retrospective record review of 212 GAD65 neurological autoimmunity samples examined at the Mayo clinic laboratory from 2003–2018, 50% had SP-SD, 43% cerebellar ataxia, 29% autoimmune epilepsy and 16% limbic encephalitis [38]. The gene discussed is GAD2; the disease is aceruloplasminemia.